Mechoulam R - Search Results

1

Pharmacokinetics of cannabidiol in dogs.

Samara E, Bialer M, Mechoulam R. Samara E, et al. Among authors: mechoulam r. Drug Metab Dispos. 1988 May-Jun;16(3):469-72. Drug Metab Dispos. 1988. PMID: 2900742

2

Looking back at Cannabis research.

Mechoulam R. Mechoulam R. Curr Pharm Des. 2000 Sep;6(13):1313-22. doi: 10.2174/1381612003399509. Curr Pharm Des. 2000. PMID: 10903394 Review.

3

Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.

Mechoulam R, Hanus L. Mechoulam R, et al. Chem Phys Lipids. 2002 Dec 31;121(1-2):35-43. doi: 10.1016/s0009-3084(02)00144-5. Chem Phys Lipids. 2002. PMID: 12505688 Review.

4

Effect of prior foot shock stress and Δ⁹-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats.

Rock EM, Limebeer CL, Petrie GN, Williams LA, Mechoulam R, Parker LA. Rock EM, et al. Among authors: mechoulam r. Psychopharmacology (Berl). 2017 Jul;234(14):2207-2217. doi: 10.1007/s00213-017-4626-5. Epub 2017 Apr 20. Psychopharmacology (Berl). 2017. PMID: 28424834

5

Cannabimimetic activity (delta 1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons.

Järbe TU, Hiltunen AJ, Lander N, Mechoulam R. Järbe TU, et al. Among authors: mechoulam r. Pharmacol Biochem Behav. 1986 Aug;25(2):393-9. doi: 10.1016/0091-3057(86)90015-8. Pharmacol Biochem Behav. 1986. PMID: 3020594

6

Comparative metabolism of cannabidiol in dog, rat and man.

Harvey DJ, Samara E, Mechoulam R. Harvey DJ, et al. Among authors: mechoulam r. Pharmacol Biochem Behav. 1991 Nov;40(3):523-32. doi: 10.1016/0091-3057(91)90358-9. Pharmacol Biochem Behav. 1991. PMID: 1806942

7

Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids.

Mechoulam R, Breuer A, Järbe TU, Hiltunen AJ, Glaser R. Mechoulam R, et al. J Med Chem. 1990 Mar;33(3):1037-43. doi: 10.1021/jm00165a024. J Med Chem. 1990. PMID: 2155318

8

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.

Linares IM, Zuardi AW, Pereira LC, Queiroz RH, Mechoulam R, Guimarães FS, Crippa JA. Linares IM, et al. Among authors: mechoulam r. Braz J Psychiatry. 2019 Jan-Feb;41(1):9-14. doi: 10.1590/1516-4446-2017-0015. Epub 2018 Oct 11. Braz J Psychiatry. 2019. PMID: 30328956 Free PMC article.

9

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Fernández-Ruiz J, et al. Among authors: mechoulam r. Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Br J Clin Pharmacol. 2013. PMID: 22625422 Free PMC article. Review.

10

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.

Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JC, Crippa JA, Zuardi AW, Mechoulam R, Guimarães FS. Breuer A, et al. Among authors: mechoulam r. PLoS One. 2016 Jul 14;11(7):e0158779. doi: 10.1371/journal.pone.0158779. eCollection 2016. PLoS One. 2016. PMID: 27416026 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results